An advocate is not the same as a health care proxy who is assigned to speak for a patient on their advanced directives.

She noted that she became a better nurse under his mentorship, thanks to the “wisdom and skills he instilled in [her].” His ...

The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...

From FDA actions to new standard-of-care potential, the breast cancer treatment arsenal continues to expand. This week’s news ...

Recent clinical developments in the treatment of platinum-resistant ovarian cancer (PROC) have introduced several novel therapeutic classes, including selective glucocorticoid receptor antagonists, ...

The FDA approved a larger vial size of nelarabine for the treatment of pediatric and adult patients with T-ALL and T-LBL. The FDA approved a larger vial size of 375 mg/75 mL for nelarabine (Arranon) ...

“Oncology nurses are unique in that we see patients for a long time. We get to know their families. We see them through graduation, through weddings, progression of disease, recurrence,” said ...

Age, Parental Status Factors in Fertility Decisions in Premenopausal Breast Cancer ...

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...

Data from the COMMIT trial demonstrated that the addition of oxaliplatin, leucovorin, 5-fluorouracil (mFOLFOX6) and bevacizumab (Avastin) to atezolizumab (Tecentriq) significantly improves progression ...

A patient acuity model drove efficient and safe staffing through data from a natural language processing model informed by oncology nurse insights. Predicting proper nurse staffing levels in infusion ...

This is the first in a 3-part series about nurses as advocates within healthcare. Many nurses think of advocacy as the most important role we play in patient care. We need to remember that to best ...